Concourse Financial Group Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-778
| Closed | -$90K | – | 11124 |
|
|
2023
Q3 | $90K | Sell |
778
-87
| -10% | -$10.1K | 0.01% | 886 |
|
|
2023
Q2 | $89K | Sell |
865
-18
| -2% | -$1.85K | 0.01% | 897 |
|
|
2023
Q1 | $96.4K | Sell |
883
-680
| -44% | -$74.2K | 0.01% | 881 |
|
|
2022
Q4 | $178K | Buy |
+1,563
| New | +$178K | 0.01% | 640 |
|
|
2022
Q3 | – | Sell |
-2,153
| Closed | -$172K | – | 11456 |
|
|
2022
Q2 | $172K | Buy |
2,153
+266
| +14% | +$21.3K | 0.01% | 632 |
|
|
2022
Q1 | $199K | Sell |
1,887
-337
| -15% | -$35.5K | 0.01% | 637 |
|
|
2021
Q4 | $240K | Buy |
2,224
+132
| +6% | +$14.2K | 0.01% | 666 |
|
|
2021
Q3 | $229K | Buy |
2,092
+52
| +3% | +$5.69K | 0.01% | 677 |
|
|
2021
Q2 | $191K | Sell |
2,040
-380
| -16% | -$35.6K | 0.01% | 732 |
|
|
2021
Q1 | $223K | Buy |
2,420
+91
| +4% | +$8.39K | 0.02% | 649 |
|
|
2020
Q4 | $170K | Buy |
2,329
+776
| +50% | +$56.6K | 0.01% | 681 |
|
|
2020
Q3 | $121K | Buy |
1,553
+1,205
| +346% | +$93.9K | 0.01% | 716 |
|
|
2020
Q2 | $19K | Buy |
348
+12
| +4% | +$655 | ﹤0.01% | 1317 |
|
|
2020
Q1 | $10K | Buy |
336
+113
| +51% | +$3.36K | ﹤0.01% | 1468 |
|
|
2019
Q4 | $8K | Buy |
223
+113
| +103% | +$4.05K | ﹤0.01% | 1519 |
|
|
2019
Q3 | $3K | Sell |
110
-125
| -53% | -$3.41K | ﹤0.01% | 1497 |
|
|
2019
Q2 | $6K | Hold |
235
| – | – | ﹤0.01% | 1704 |
|
|
2019
Q1 | $6K | Sell |
235
-147
| -38% | -$3.75K | ﹤0.01% | 1710 |
|
|
2018
Q4 | $7K | Buy |
382
+19
| +5% | +$348 | ﹤0.01% | 1561 |
|
|
2018
Q3 | $7K | Buy |
+363
| New | +$7K | ﹤0.01% | 1310 |
|